Nifty
Sensex
:
:
17853.20
60048.47
30.25 (0.17%)
163.11 (0.27%)

Pharmaceuticals & Drugs - API

Rating :
52/99

BSE: 532482 | NSE: GRANULES

321.80
24-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  323.50
  •  329.50
  •  320.60
  •  321.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1833473
  •  5950.36
  •  437.95
  •  295.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,961.51
  • 14.26
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,539.67
  • 0.47%
  • 3.51

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.04%
  • 4.04%
  • 29.74%
  • FII
  • DII
  • Others
  • 18.35%
  • 2.65%
  • 3.18%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.35
  • 18.08
  • 12.41

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.85
  • 23.40
  • 17.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 33.77
  • 31.49
  • 43.06

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.42
  • 16.48
  • 14.60

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.22
  • 2.86
  • 2.88

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.25
  • 10.55
  • 10.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
849.85
735.60
15.53%
799.31
599.88
33.24%
844.51
703.96
19.97%
858.12
699.53
22.67%
Expenses
648.42
552.01
17.47%
597.31
499.94
19.48%
632.95
540.81
17.04%
601.71
555.93
8.23%
EBITDA
201.43
183.59
9.72%
202.01
99.95
102.11%
211.56
163.15
29.67%
256.41
143.60
78.56%
EBIDTM
23.70%
24.96%
25.27%
16.66%
25.05%
23.18%
29.88%
20.53%
Other Income
7.62
5.63
35.35%
3.28
22.52
-85.44%
16.41
3.51
367.52%
3.22
8.67
-62.86%
Interest
6.79
5.95
14.12%
6.82
6.57
3.81%
7.24
6.73
7.58%
6.27
6.85
-8.47%
Depreciation
39.38
34.08
15.55%
44.48
38.97
14.14%
36.85
38.99
-5.49%
36.06
30.32
18.93%
PBT
162.87
149.19
9.17%
153.99
136.70
12.65%
183.88
88.90
106.84%
217.30
115.10
88.79%
Tax
42.67
37.74
13.06%
26.42
44.36
-40.44%
37.08
24.87
49.10%
53.67
19.31
177.94%
PAT
120.20
111.45
7.85%
127.57
92.34
38.15%
146.81
64.03
129.28%
163.63
95.79
70.82%
PATM
14.14%
15.15%
15.96%
15.39%
17.38%
9.10%
19.07%
13.69%
EPS
4.85
4.51
7.54%
5.15
3.63
41.87%
5.93
2.52
135.32%
6.61
3.77
75.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
3,351.79
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
653.97
Net Sales Growth
22.37%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
17.98%
43.37%
16.88%
 
Cost Of Goods Sold
1,482.75
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
645.25
466.92
414.36
Gross Profit
1,869.04
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
450.61
297.45
239.60
GP Margin
55.76%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
36.64%
Total Expenditure
2,480.39
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
574.68
Power & Fuel Cost
-
68.85
59.74
57.67
48.22
38.67
34.97
45.73
36.70
37.71
26.28
% Of Sales
-
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
4.02%
Employee Cost
-
324.29
259.04
209.82
165.21
140.19
117.57
106.96
85.84
59.71
45.46
% Of Sales
-
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
6.95%
Manufacturing Exp.
-
228.39
177.94
157.62
120.84
88.60
66.97
50.89
38.68
24.34
18.90
% Of Sales
-
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
3.53%
3.18%
2.89%
General & Admin Exp.
-
172.28
125.63
99.96
83.05
67.65
60.38
59.84
44.42
26.96
21.31
% Of Sales
-
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
4.05%
3.53%
3.26%
Selling & Distn. Exp.
-
159.80
112.17
91.84
83.08
81.37
67.75
71.70
85.04
61.70
47.62
% Of Sales
-
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
7.28%
Miscellaneous Exp.
-
37.42
57.88
22.69
9.49
15.61
8.62
2.24
1.64
2.01
47.62
% Of Sales
-
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
0.11%
EBITDA
871.41
855.23
525.32
384.04
278.42
298.84
275.89
208.61
158.29
85.02
79.29
EBITDA Margin
26.00%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
12.12%
Other Income
30.53
26.88
36.56
26.68
10.84
9.93
5.62
4.34
4.31
2.06
1.38
Interest
27.12
26.28
27.02
28.46
33.06
32.26
37.07
32.35
20.43
17.67
16.99
Depreciation
156.77
151.46
136.95
105.48
76.20
71.51
58.40
52.65
29.81
23.08
20.70
PBT
718.04
704.36
397.90
276.78
180.00
204.99
186.03
127.96
112.36
46.32
42.98
Tax
159.84
154.91
115.73
89.11
63.40
65.20
61.15
37.05
37.13
13.76
13.02
Tax Rate
22.26%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
30.29%
PAT
558.21
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
29.95
PAT before Minority Interest
558.21
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
29.95
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
16.65%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
4.58%
PAT Growth
53.52%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
20.84%
130.98%
8.75%
 
EPS
22.54
22.18
12.51
7.58
4.71
5.64
5.04
3.67
3.04
1.31
1.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
355.96
274.85
245.09
Share Capital
24.77
25.42
25.42
25.38
22.87
21.67
20.43
20.28
20.13
20.06
Total Reserves
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
335.43
254.41
225.03
Non-Current Liabilities
366.30
485.98
552.63
488.19
187.99
246.62
356.52
343.51
202.00
112.60
Secured Loans
333.81
414.83
478.78
433.13
123.90
183.66
302.59
295.86
174.85
87.30
Unsecured Loans
7.34
6.69
0.00
0.00
0.34
0.55
0.62
13.38
0.65
0.75
Long Term Provisions
24.84
21.50
12.58
7.70
7.25
5.58
4.03
3.97
2.04
1.53
Current Liabilities
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
292.54
205.78
213.63
Trade Payables
541.05
356.88
323.48
274.35
215.98
181.10
187.63
135.54
91.84
75.52
Other Current Liabilities
200.77
153.16
113.60
69.84
93.43
79.21
88.98
47.78
23.77
31.39
Short Term Borrowings
409.27
371.69
454.21
525.10
473.83
392.85
124.97
100.91
85.46
102.06
Short Term Provisions
22.01
11.66
5.20
8.62
3.90
1.58
13.45
8.30
4.71
4.66
Total Liabilities
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
992.01
682.63
571.32
Net Block
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
482.47
263.46
250.42
Gross Block
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
653.90
387.41
354.50
Accumulated Depreciation
813.15
671.26
528.69
422.90
339.32
263.05
227.21
171.43
123.95
104.07
Non Current Assets
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
611.55
388.87
310.52
Capital Work in Progress
239.08
294.20
495.95
514.52
267.43
76.56
62.03
124.56
108.80
29.30
Non Current Investment
18.99
19.34
210.42
156.56
108.23
70.11
0.19
0.19
0.19
0.19
Long Term Loans & Adv.
125.61
76.89
45.72
35.91
30.56
38.37
20.76
4.33
16.42
30.50
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.15
0.00
0.00
0.12
Current Assets
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
376.92
288.88
260.26
Current Investments
0.00
109.85
0.00
0.00
0.00
0.00
0.00
0.00
9.46
0.00
Inventories
782.18
438.43
384.21
279.95
269.18
253.72
224.52
174.16
136.48
109.91
Sundry Debtors
765.42
662.04
673.54
628.25
417.70
375.35
136.91
110.91
71.02
95.01
Cash & Bank
271.04
283.94
89.04
115.64
49.80
130.29
65.31
41.75
41.71
31.98
Other Current Assets
178.35
42.60
36.99
48.64
91.49
58.65
73.63
50.10
30.21
23.36
Short Term Loans & Adv.
127.61
91.83
98.46
114.09
51.66
48.68
2.05
28.76
16.93
13.18
Net Current Assets
823.90
735.30
385.76
308.65
41.03
163.25
85.33
84.38
83.09
46.63
Total Assets
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72
992.01
682.64
571.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
107.95
91.18
25.60
PBT
704.36
425.64
276.78
180.00
204.99
186.03
127.96
112.36
46.32
42.98
Adjustment
194.43
156.88
149.85
107.45
95.14
92.63
85.37
50.39
41.46
37.74
Changes in Working Capital
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
-43.61
Cash after chg. in Working capital
623.84
595.27
350.69
57.42
247.77
198.97
182.00
131.73
102.39
37.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
-11.51
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
-54.47
Net Fixed Assets
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
-54.67
Net Investments
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
-94.69
-17.96
-10.20
Others
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
10.40
Cash from Financing Activity
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
146.72
46.33
48.86
Net Cash Inflow / Outflow
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
0.04
9.72
19.99
Opening Cash & Equivalents
185.93
83.02
108.03
42.37
124.35
54.85
41.75
41.71
31.98
11.99
Closing Cash & Equivalent
41.84
185.93
83.02
108.03
42.37
130.29
65.31
41.75
41.71
31.98

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
86.85
71.80
59.73
51.17
39.40
29.20
20.98
17.36
13.40
12.19
ROA
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
8.98%
5.19%
5.95%
ROE
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
12.90%
ROCE
25.38%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
14.89%
Fixed Asset Turnover
1.97
1.75
1.78
1.55
1.59
1.66
1.77
2.14
2.11
1.96
Receivable days
65.94
83.34
100.03
112.83
100.84
67.60
33.47
29.73
38.66
45.82
Inventory Days
56.39
51.34
51.03
59.23
66.49
63.11
54.79
50.77
57.37
50.89
Payable days
62.54
58.20
54.96
62.37
64.87
59.99
53.57
43.67
44.19
40.05
Cash Conversion Cycle
59.78
76.48
96.10
109.70
102.46
70.72
34.69
36.83
51.84
56.66
Total Debt/Equity
0.39
0.49
0.65
0.75
0.73
1.01
1.14
1.25
1.00
0.83
Interest Cover
27.80
16.75
10.72
6.44
7.36
6.02
4.96
6.50
3.62
3.53

News Update:


  • Granules India recalling over 1.14 crore Naproxen Sodium tablets
    13th Sep 2021, 10:42 AM

    The company's US-based unit is recalling the affected lot due to CGMP deviations

    Read More
  • Granules India gets licence from DRDO to manufacture, market COVID-19 drug
    3rd Sep 2021, 10:16 AM

    The company is working closely with the DRDO team to launch the product in India at the earliest

    Read More
  • Granules India gets marketing approval for Acetaminophen Extended-Release Tablets
    30th Aug 2021, 11:51 AM

    The drug will be manufactured at the Granules manufacturing facility located in Gagillapur, Hyderabad

    Read More
  • Granules India reports 8% rise in Q1 consolidated net profit
    28th Jul 2021, 11:44 AM

    Total income of the company increased by 15.68% at Rs 857.47 crore for Q1FY22

    Read More
  • Granules India’s arm clears audit by US health regulator
    22nd Jul 2021, 11:41 AM

    The FDA issued two minor observations during the audit

    Read More
  • USFDA completes inspection at facility of Granules India’s arm
    28th Jun 2021, 09:25 AM

    This is a pre-approval inspection for the products filed from this facility

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.